Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: Biosimilars, Novel Approvals, And Ebola

Nov 11 2019

• By Michael Cipriano

Keeping Track Feature image

Related Content

Tired Of Winning? When It Comes To US FDA Appeals, “Denied” Can Still Mean Victory

Oct 12 2018

Keeping Track: US FDA Approvals For Ibsrela, Gvoke And Nucala; A BTD For Tepotinib

Sep 13 2019

Keeping Track: A Novel Approval For Fluorodopa F 18, A Tentative Approval For Vumerity, And A Missed Goal Date For Zilretta

Oct 20 2019

Is One Flu Vaccine Better Than Another For Older Adults? CDC Aims To Find Out

Nov 01 2019

Merck's Ebola Vaccine Will Get US FDA Decision Before March Review Deadline

Nov 01 2019

Biosimilars: US FDA Ends FY 2019 With Record Number Of Approvals, One Complete Response Letter

Oct 11 2019

Keeping Track: US FDA Approves Pfizer’s Vyndaqel, Jacobus’ Ruzurgi, But Nixes Acacia’s Barhemsys Again

May 13 2019

US FDA's Antimicrobial Head Ed Cox Leaves For Regeneron; Agency Needs New LPAD Champion

Aug 27 2019

Keeping Track: A Quintet Of Novel Approvals

Aug 18 2019

Keeping Track: US FDA Greenlights Two More Novel Drugs, But Smacks Down Golodirsen

Aug 23 2019

Keeping Track: Thumbs Up For Zulresso And Sunosi, Thumbs Down For Zynquista And IV Meloxicam

Mar 24 2019

Biosimilars: Sandoz Pegfilgrastim Review, Amgen Adalimumab Launch Extended To 2018

Oct 29 2016

Keeping Track: Thumbs Up For Doptelet And Palynziq, Thumbs Down For Methylene Blue MMX And Meloxicam

May 29 2018

Celgene Gives Reassurances That Key Products And Programs Remain On Track

Feb 01 2019

Rhythm Preparing NDA Submission In Rare Genetic Obesity Disorders

Aug 07 2019

'Totality Of Data' Make A Case For Luspatercept In Beta-Thalassemia, MDS

Dec 03 2018

Teva/Celltrion's Truxima Is First Biosimilar Rituxan To Reach US Market

Nov 07 2019

Related Companies

Novartis AG

Novartis AG

Amgen, Inc.

Bristol Myers Squibb Company

RedHill Biopharma Ltd.

Sanofi

Regeneron Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc.

Societal CDMO, Inc.

Viatris Inc.

Biocon, Ltd.

Coherus Oncology, Inc.

Teva Pharmaceutical Industries Ltd.

Bristol Myers Squibb Company

Cumberland Pharmaceuticals Inc.

Amneal Pharmaceuticals, Inc.

Allergan plc

Merck & Co., Inc.

Lumos Pharma, Inc.

Boehringer Ingelheim GmbH

Takeda Pharmaceutical Co. Ltd.

Harmony Biosciences Holdings, Inc.

Additional Topics

United States Approvals Drug Review Regulation US FDA Performance Tracker BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window